Episode Details
Back to EpisodesColossal GenoMorph maps about 2,300 dodo gene-edit targets, narrows lab testing
Description
Colossal says its GenoMorph AI combines developmental and comparative data from more than 70 bird species to prioritize roughly 2,300 candidate gene-editing targets tied to dodo appearance. The company emphasizes these are testable hypotheses, not validated edits, and plans lab experiments using lipid nanoparticles and Nicobar pigeon cells to evaluate effects. The announcement also drew an outside financing signal via NeoGenesis Capital, while GenoMorph is presented as an internal research tool rather than a commercial product.
Read the full story: https://runtimewire.com/article/colossal-genomorph-dodo-gene-editing-targets
Get breaking AI news the moment it happens. Sign up free at RuntimeWire: https://runtimewire.com/sign-up
More from RuntimeWire: https://runtimewire.com